These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2875 related articles for article (PubMed ID: 11559546)

  • 1. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
    del Rincón SV; Rousseau C; Samanta R; Miller WH
    Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
    Surmacz E; Bartucci M
    J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H; Conrad SE
    Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
    Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
    Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I receptor activity in human medulloblastomas.
    Del Valle L; Enam S; Lassak A; Wang JY; Croul S; Khalili K; Reiss K
    Clin Cancer Res; 2002 Jun; 8(6):1822-30. PubMed ID: 12060623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
    Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
    Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.
    Mamay CL; Mingo-Sion AM; Wolf DM; Molina MD; Van Den Berg CL
    Oncogene; 2003 Jan; 22(4):602-14. PubMed ID: 12555073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
    Jackson JG; Yee D
    Growth Horm IGF Res; 1999 Oct; 9(5):280-9. PubMed ID: 10543935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.
    Satyamoorthy K; Li G; Vaidya B; Patel D; Herlyn M
    Cancer Res; 2001 Oct; 61(19):7318-24. PubMed ID: 11585772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
    Kurokawa H; Arteaga CL
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.
    Frogne T; Jepsen JS; Larsen SS; Fog CK; Brockdorff BL; Lykkesfeldt AE
    Endocr Relat Cancer; 2005 Sep; 12(3):599-614. PubMed ID: 16172194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 144.